The nerve growth factor (NGF) receptor was characterized by using a new series of anti-receptor monoclonal antibodies (MAbs). These MAbs (i) showed significantly greater reactivity with a melanoma cell line expressing higher levels of NGF receptor, (ii) inhibited the binding of '251-labeled NGF to its receptor, and (iii) immunoprecipitated both metabolically labeled and '251-labeled NGF affinity-labeled receptor. These experiments defined the receptor as a 75-kDa cell-surface protein. The NGF receptor was visualized by immunoperoxidase staining in tissue sections of human nevi, melanomas, neurofibromas, a pheochromocytoma, and peripheral nerves. Uniform staining of the cytoplasm suggests that, in addition to cell-surface NGF receptors, there is a population of intracellular receptors.
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Nerve growth factor (NGF) has been the subject of extensive study because of its importance for regulation of development of sympathetic and sensory neurons and possibly other neural crest-derived cell types as well (1) . Involvement of NGF in neural crest tumors such as melanoma has been suggested but never directly demonstrated. Efforts to identify oncogenes or oncogene-encoded products in malignant melanoma have been inconclusive (2) , but the NGF receptor is a reasonable candidate particularly since, as we demonstrate in this study, it is expressed on melanoma cells in much greater quantities than on normal melanocytes. Progress in determining the relevance of this receptor to the transformed phenotype has been slow because the NGF receptor is not well characterized, nor are there good anti-receptor monoclonal antibodies (MAbs) or polyclonal antibodies available. From a collection of MAbs to melanoma cell surface antigens, we have identified precipitating MAbs to the NGF receptor and, using these MAbs, have carefully defined the biochemical nature of the NGF receptor and its distribution among normal and transformed neural crest tissues.
MATERIALS AND METHODS
Human Cell Lines. Human melanoma cell line WM245 was derived as described (3) . Human melanoma line A875 (4) was a gift of G. J. Todaro and human melanoma line SK MEL 37, a gift of K. 0. Lloyd of the Sloan-Kettering Institute. Cells were grown in minimum Eagle's medium or L15 medium supplemented with 10% fetal bovine serum.
Mouse MAbs. The preparation and characterization of anti-melanoma MAbs used in this study have been described (5) except for ME20.4 (IgG), which was prepared by using WM245 melanoma cells as immunogen in mice. MAbs were used as hybridoma culture supernatant; in some experiments, immunoglobulin from ascites prepared in pristaneprimed BALB/c mice was purified by precipitation with 50% ammonium sulfate and chromatography with DEAE Affi-Gel Blue column (Bio-Rad).
Binding Assays. NGF was isolated and iodinated using lactoperoxidase as described (6, 7 
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Proc. Nati. Acad. Sci. USA 81 (1984) versity of Pennsylvania) were sampled, and representative portions were stored at -70'C. Cryostat sections (5 /am) were cut, dried overnight, fixed in acetone for 10 min, and allowed to dry. After a 3-min wash in Pi/NaCl, the sections were successfully incubated for 15 min with hybridoma culture supernatant (1/50), biotinylated anti-mouse antibody (1/75) (Vector Laboratories, Burlingame, CA), and avidinbiotinylated peroxidase complex (Vector Laboratories) with 3-min washes in Pi/NaCl between all steps. After another Pi/NaCl wash, aminoethylcarbazole (20 mg of aminoethylcarbazole in 5 ml of N,N-dimethylformamide mixed with 95 ml of 0.05 M acetate buffer, pH 5.2/0.03% H2O2) was applied for 10 min. Sections were rinsed in water, counterstained with hematoxylin, dehydrated, and mounted.
Tissue from the files of the Pigmented Lesion Group or the Division of Surgical Pathology (Hospital of the University of Pennsylvania) and a cell pellet of A875 cells were fixed in Bouin's solution or neutral buffered formalin and were paraffin-embedded. Sections (5 jam) were deparaffinized, washed for 5 min in running water, and stained as above.
RESULTS

Correlation Between Expression of Melanoma-Associated
Antigens and NGF Receptors. To identify MAbs that might be directed against the NGF receptor, the reactivities in RIA of eight anti-melanoma MAbs with A875, a human melanoma line unusually rich in NGF receptor (4), and SK MEL 37, a human melanoma line with far fewer NGF receptors, were compared ( tThe number in parentheses is the Mr X 10-3, as determined by NaDodSO4/polyacrylamide gel electrophoresis (5) . from hybridomas ME83-29, ME82-13, ME80-25, and ME81-22, all of which resulted from the same fusion as ME82-11, had similar specificities, and may synthesize the same MAb, also strongly inhibited binding of 1 5I-NGF. Binding was inhibited in a dose-dependent manner by purified MAbs (Fig.  3B) , requiring 700 ng of ME82-11 IgG and 300 ng of ME20.4
per ml for 50% inhibition.
The direct interaction between the MAbs and the NGF receptor was demonstrated by using affinity-labeled NGF receptor. A875 cells were incubated with 125I-NGF and with the crosslinking agent ethyldimethylisopropylaminocarbodiimide and then were solubilized with detergent. The apparent molecular weight of the affinity-labeled NGF receptor in this gel system was 90,000, which is slightly lower than previously reported (12) . A second, much weaker band of apparent Mr 200,000 was detected in some but not all experiments. The affinity-labeled NGF receptor was immunoprecipitated with MAbs ME20.4, ME81-22, ME80-25, ME82-13, IgG, ng/ml ME83-29, and ME82-11 (Fig. 4, lanes 2-7) but not with P3X63Ag8 or P,/NaCI (Fig. 4, lanes 8 and 9) . When 1984) reactivity, whereas two other nevi showed 10% reactivity. In contrast to the reactivity of lesions in frozen sections, no paraffin-embedded melanomas or nevi other than the A875 cell line were positive for staining. However, cutaneous nerves reacted in five of five paraffin samples and in all frozen sections tested, serving as an internal positive control. This staining was localized in the perineurium and endoneurium and/or Schwann cell cytoplasm, indicating that the neural sheath is rich in NGF receptor. Of four neurofibromas examined as fixed sections, two were positive. A corresponding to the M,. 130,000-140,000 described in rabbit sympathetic ganglia (14) or in PC12 cells (16) . Previous studies have suggested multiple forms of the NGF receptor. NGF receptors are heterogeneous with respect to kinetics and affinity of NGF binding (17, 18) , but it is likely that these receptor forms are interconvertible and represent a single receptor protein (12, (16) (17) (18) (19) (20) (21) (25) .
In the light of the recent discoveries linking growth factorgrowth-factor receptor systems with oncogenesis (26) , it is worth considering whether the abundant expression of NGF receptors on certain tumors is of consequence for their neoplastic growth. The anti-receptor MAbs have revealed that melanomas both in culture (5) and in vivo ( Table 2 ) express much greater amounts of the NGF receptor than do normal melanocytes.
